Fosun Pharmaceutical Shanghai Sells 2,854,607 Shares of Nature's Sunshine Products, Inc. (NASDAQ:NATR) Stock

Nature's Sunshine Products, Inc. (NASDAQ:NATR - Get Free Report) major shareholder Fosun Pharmaceutical Shanghai sold 2,854,607 shares of the stock in a transaction dated Friday, June 27th. The shares were sold at an average price of $11.46, for a total value of $32,713,796.22. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Major shareholders that own more than 10% of a company's stock are required to disclose their transactions with the SEC.

Nature's Sunshine Products Trading Up 1.6%

NATR traded up $0.23 during trading on Friday, hitting $14.50. The stock had a trading volume of 390,750 shares, compared to its average volume of 50,684. The company has a 50 day simple moving average of $13.86 and a 200-day simple moving average of $13.93. The firm has a market cap of $267.67 million, a PE ratio of 27.36 and a beta of 1.16. Nature's Sunshine Products, Inc. has a 12 month low of $10.81 and a 12 month high of $18.06.

Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) last announced its earnings results on Tuesday, May 6th. The company reported $0.25 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.16 by $0.09. Nature's Sunshine Products had a net margin of 2.22% and a return on equity of 6.98%. The business had revenue of $113.25 million for the quarter, compared to analyst estimates of $109.39 million.

Institutional Trading of Nature's Sunshine Products

Institutional investors have recently modified their holdings of the company. Proficio Capital Partners LLC bought a new position in Nature's Sunshine Products during the fourth quarter worth about $200,000. Bailard Inc. bought a new position in Nature's Sunshine Products in the 4th quarter valued at $302,000. Amundi bought a new position in Nature's Sunshine Products in the fourth quarter valued at about $63,000. Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Nature's Sunshine Products in the 4th quarter valued at about $314,000. Finally, American Century Companies Inc. grew its holdings in Nature's Sunshine Products by 2.7% during the 4th quarter. American Century Companies Inc. now owns 304,432 shares of the company's stock worth $4,463,000 after acquiring an additional 8,085 shares during the period. Institutional investors and hedge funds own 79.40% of the company's stock.

Wall Street Analyst Weigh In

Separately, DA Davidson reaffirmed a "buy" rating and set a $19.00 target price on shares of Nature's Sunshine Products in a research report on Tuesday, June 3rd.

Nature's Sunshine Products Company Profile

Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.